Human immunodeficiency virus type 1 (HIV-1) induces activation of multiple stats in CD4+ cells of lymphocyte or monocyte/macrophage lineages

Journal of Leukocyte Biology

Volumn 73, Issue 3, 2003, Pages 407-416

  Kohler, James J ^a   Tuttle, Daniel L ^a   Coberley, Carter R ^a   Sleasman, John W ^a   Goodenow, Maureen M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

CCR5; CXCR4; EMSA; Pathogenesis

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; ENVELOPE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 2; MONOCLONAL ANTIBODY; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; DNA BINDING PROTEIN; GLYCOPROTEIN GP 120; MILK PROTEIN; STAT1 PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CELL ACTIVATION; CELL LINEAGE; CELL STRAIN HUT78; CELL STRAIN U937; DOSE RESPONSE; GEL MOBILITY SHIFT ASSAY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KINETICS; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MONOCYTE; MONONUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN PHOSPHORYLATION; VIRUS REPLICATION; CD4+ T LYMPHOCYTE; CELL CULTURE; METABOLISM; PHYSIOLOGY; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; CELL LINEAGE; DNA-BINDING PROTEINS; GENE PRODUCTS, ENV; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MACROPHAGES; MILK PROTEINS; MONOCYTES; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0037686172     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0702358     Document Type: Article

References (73)

1. Sleasman, J. W., Goodenow, M. M. (1991) Pathogenesis and natural history of HIV infection. J. Fla. Med. Assoc. 78, 678-681.
2. Fauci, A. S. (1996) Host factors and the pathogenesis of HIV-induced disease. Nature 384, 529-534.
3. Lane, H. C., Depper, J. M., Greene, W. C., Whalen, G., Waldmann, T. A., Fauci, A. S. (1985) Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N. Engl. J. Med. 313, 79-84.
4. Jacobson, D. L., McCutchan, J. A., Spechko, P. L., Abramson, I., Smith, R. S., Bartok, A., Boss, G. R., Durand, D., Bozzette, S. A., Spector, S. A., et al. (1991) The evolution of lymphadenopathy and hypergammaglobulinemia are evidence for early and sustained polyclonal B lymphocyte activation during human immunodeficiency virus infection. J. Infect. Dis. 163, 240-246.
5. Weimer, R., Daniel, V., Zimmerman, R., Schimpf, K., Opelz, G. (1991) Autoantibodies against CD4 cells are associated with CD4 helper defects in human immunodeficiency virus-infected patients. Blood 77, 133-140.
6. McMichael, A. J., Rowland-Jones, S. L. (2001) Cellular immune responses to HIV. Nature 410, 980-987.
7. Champagne, P., Ogg, G. S., King, A. S., Knabenhans, C., Ellefsen, K., Nobile, M., Appay, V., Rizzardi, G. P., Fleury, S., Lipp, M., Forster, R., Rowland-Jones, S., Sekaly, R. P., McMichael, A. J., Pantaleo, G. (2001) Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410, 106-111.
8. Lieberman, J., Shankar, P., Manjunath, N., Andersson, J. (2001) Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 98, 1667-1677.
9. Ennen, J., Seipp, I., Norley, S. G., Kurth, R. (1990) Decreased accessory cell function of macrophages after infection with human immunodeficiency virus type 1 in vitro. Eur. J. Immunol. 20, 2451-2456.
10. Smith, P. D., Ohura, K., Masur, H., Lane, H. C., Fauci, A. S., Wahl, S. M. (1984) Monocyte function in the acquired immune deficiency syndrome: defective chemotaxis. J. Clin. Invest. 74, 2121-2128.
11. Shearer, G. M., Clerici, M. (1991) Early T-helper cell defects in HIV infection. AIDS 5, 245-253.
12. Leonard, W. J., O'Shea, J. J. (1998) JAKS and STATS: biological implications. Annu. Rev. Immunol. 16, 293-322.
13. Pellegrini, S., Dusanter-Fourt, I. (1997) The structure, regulation, and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs). Eur. J. Biochem. 248, 615-633.
14. O'Shea, J. J. (1997) JAKs, STATs, cytokine signal transduction, and immunoregulation: are we there yet? Immunity 7, 1-11.
15. Decker, T., Meinke, A. (1997) JAKs, STATs and the immune system. Immunobiology, 198, 99-111.
16. Ihle, J. N. (1996) STATs: signal transducers and activators of transcription. Cell 84, 331-334.
17. Ward, A. C., Touw, I., Yoshimura, A. (2000) The JAK-STAT pathway in normal and perturbed hematopoiesis. Blood 95, 19-29.
18. Ransohoff, R. M. (1998) Cellular responses to interferons and other cytokines: the JAK-STAT paradigm. N. Engl. J. Med. 338, 616-618.
19. Welte, T., Leitenberg, D., Dittel, B. N., al-Ramadi, B. K., Xie, B., Chin, Y. E., Janeway Jr., C. A., Bothwell, A. L. M., Bottomly, K., Fu, X-Y. (1999) STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation. Science 283, 222-225.
20. Aittomäki, S., Pesu, M., Groner, B., Jänne, O. A., Palvimo, J. J., Silvennoinen, O. (2000) Cooperation among STAT1, glucocorticoid receptor, and PU.1 in transcriptional activation of the high-affinity Fcγ receptor I in monocytes. J. Immunol. 164, 5689-5697.
21. Lee, I-H., Li, W. P., Hisert, K. B., Ivashkiv, L. B. (1999) Inhibition of interleukin 2 signaling and signal transducer and activator of transcription (STAT)5 activation during T cell receptor-mediated feedback inhibition of T cell expansion. J. Exp. Med. 190, 1263-1274.
22. Frucht, D. M., Aringer, M., Galon, J., Danning, C., Brown, M., Fan, S., Centola, M., Wu, C-Y., Yamada, N., Gabalawy, H. E., O'Shea, J. J. (2000) STAT4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation. J. Immunol. 164, 4659-4664.
23. Greenberg, P. D., Riddell, S. R. (1999) Deficient cellular immunity-finding and fixing the defects. Science 285, 546-551.
24. Garcia, R., Jove, R. (1998) Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. J. Biomed. Sci. 5, 79-85.
25. Garcia, R., Yu, C-L., Hudnall, A., Catlett, R., Nelson, K. L., Smithgall, T., Fujita, D. J., Ethier, S. P., Jove, R. (1997) Constitutive activation of STAT3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ. 8, 1267-1276.
26. Bovolenta, C., Camorali, L., Lorini, A., Ghezzi, S., Vicenzi, E., Lazzarin, A., Poli, G. (1999) Constitutive activation of STATs upon in vivo human immunodeficiency virus infection. Blood 94, 4202-4209.
27. Shrikant, P., Benos, D. J., Tang, L. P., Benveniste, E. N. (1996) HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells. Involvement of Janus kinase/signal transducer and activator of transcription and protein kinase C signaling pathways. J. Immunol. 156, 1307-1314.
28. Gootenberg, J. E., Ruscetti, F. W., Mier, J. W., Gazdar, A., Gallo, R. C. (1981) Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor. J. Exp. Med. 154, 1403-1418.
29. Sundstrom, C., Nilsson, K. (1976) Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 17, 565-577.
30. Graham, F. L., Smiley, J., Russell, W. C., Nairn, R. (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-74.
31. Tuttle, D. L., Harrison, J. K., Anders, C., Sleasman, J. W., Goodenow, M. M. (1998) Expression of CCR5 increases during moncyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. J. Virol. 72, 4962-4969.
32. Wain-Hobson, S., Vartanian, J. P., Henry, M., Chenciner, N., Cheynier, R., Delassus, S., Martins, L. P., Sala, M., Nugeyre, M. T., Geutard, D., et al. (1991) LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur. Science 252, 961-965.
33. Barre-Sinonssi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vezinet-Brun, F., Rouzioux, C., Rozenbaum, W., Montagnier, L. (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220, 868-871.
34. O'Brien, W. A., Koyanagi, Y., Namazie, A., Zhao, J. Q., Diagne, A., Idler, K., Zack, J. A., Chen, I. S. (1990) HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature 348, 69-73.
35. Koyanagi, Y., O'Brien, W. A., Zhao, J. Q., Golde, D. W., Gason, J. C., Chen, I. S. (1988) Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 241, 1673-1675.
36. Koyanagi, Y., Miles, S., Mitsuyasu, R. T., Merrill, J. E., Vinters, H. V., Chen, I. S. (1987) Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236, 819-822.
37. He, J., Choe, S., Walker, R., Di Marzio, P., Morgan, D. O., Landau, N. R. (1995) Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69, 6705-6711.
38. Sanchez-Pescador, R., Power, M. D., Barr, P. J., Steimer, K. S., Stempien, M. M., Brown-Shimer, S. L., Gee, W. W., Renard, A., Randolph, A., Levy, J. A., et al. (1985) Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science 227, 484-492.
39. Haigwood, N. L., Shuster, J. R., Moore, G. K., Lee, H., Skiles, P. V., Higgins, K. W., Barr, P. J., George-Nascimento, C., Steimer, K. S. (1990) Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies. AIDS Res. Hum. Retroviruses 6, 855-869.
40. Steimer, K. S., Puma, J. P., Power, M. D., Powers, M. A., George-Nascimento, C., Stephans, J. C., Levy, J. A., Sanchez-Pescador, R., Luciw, P. A., Barr, P. J., et al. (1986) Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria. Virology 150, 283-290.
41. Levy, J. A., Hoffman, A. D., Kramer, S. M., Landis, J. A., Shimabukuro, J. M., Oshiro, L. S. (1984) Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 225, 840-842.
42. Haigwood, N. L., Barker, C. B., Higgins, K. W., Skiles, P. V., Moore, G. K., Mann, K. A., Lee, D. R., Eichberg, J. W., Steimer, K. S. (1990) Evidence for neutralizing antibodies directed against conformational epitopes of HIV-1 gp120. Vaccines 90, 313-320.
43. Scandella, C. J., Kilpatrick, J., Lidster, W., Parker, C., Moore, J. P., Moore, G. K., Mann, K. A., Brown, P., Coates, S., Chapman, B., et al. (1993) Nonaffinity purification of recombinant gp120 for use in AIDS vaccine development. AIDS Res. Hum. Retroviruses 9, 1233-1244.
44. Murthy, K. K., Cobb, E. K., el Amad, Z., Ortega, H., Hsueh, F. C., Satterfield, W., Lee, D. R., Kalish, M. L., Haigwood, N. L., Kennedy, R. C., Steimer, K. S., Schultz, A., Levy, J. A. (1996) Titration of a vaccine stock preparation of human immunodeficiency virus type 1SF2 in cultured lymphocytes and in chimpanzees. AIDS Res. Hum. Retroviruses 12, 1341-1348.
45. Tuttle, D. L., Anders, C. B., Aquino-de Jesus, M. J., Poole, P. P., Lamers, S. L., Briggs, D. R., Pomeroy, S. M., Peden, K. W. C., Andiman, W. A., Sleasman, J. W., Goodenow, M. M. (2002) Increased replication by non-syncytium-inducing HIV-1 isolates in monocyte-derived macrophages is linked to advanced disease in infected children. AIDS Res. Hum. Retroviruses 18, 357-366.
46. Briggs, D. R., Tuttle, D. L., Sleasman, J. W., Goodenow, M. M. (2000) Envelope V3 amino acid sequence predicts HIV-1 phenotype (co-receptor usage and tropism for macrophages). AIDS 14, 2937-2939.
47. Schreiber, E., Matthias, P., Muller, M. M., Schaffner, W. (1989) Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17, 6419.
48. Wakao, H., Gouilleux, F., Groner, B. (1994) Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J. 13, 2182-2191.
49. Flanagan, J. R., Beeker, K. G., Ennist, D. L., Gleason, S. L., Driggers, P. H., Levi, B. Z., Appella, E., Ozato, K. (1992) Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus. Mol. Cell. Biol. 12, 38-44.
50. Bovolenta, C., Lorini, A. L., Mantelli, B., Camorali, L., Novelli, F., Biswas, P., Poli, G. (1999) A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1. J. Immunol. 162, 323-330.
51. Sattentau, Q. J., Weiss, R. A. (1988) The CD4 antigen: physiological ligand and HIV receptor. Cell 52, 631-633.
52. Heim, M. H., Moradpour, D., Blum, H. E. (1999) Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J. Virol. 73, 8469-8475.
53. Miller, D. M., Rahill, B. M., Boss, J. M., Lairmore, M. D., Durbin, J. E., Waldman, W. J., Sedmak, D. D. (1998) Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the JAK/STAT pathway. J. Exp. Med. 187, 675-683.
54. Didcock, L., Young, D. F., Goodbourn, S., Randall, R. E. (1999) The V protein of Simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J. Virol. 73, 9928-9933.
55. Gires, O., Kohlhuber, F., Kilger, E., Baumann, M., Kieser, A., Kaiser, C., Zeidler, R., Scheffer, B., Ueffing, M., Hammerschmidt, W. (1999) Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. EMBO J. 18, 3064-3073.
56. Takemoto, S., Mulloy, J. C., Cereseto, A., Migone, T-S., Patel, B. K. R., Matsuoka, M., Yamaguchi, K., Takatsuki, K., Kamihira, S., White, J. D., Leonard, W. J., Waldmann, T., Franchini, G. (1997) Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc. Natl. Acad. Sci. USA 94, 13897-13902.
57. Migone, T-S., Lin, J-X., Cereseto, A., Mulloy, J. C., O'Shea, J. J., Franchini, G., Leonard, W. J. (1995) Constitutively activated JAK-STAT pathway in T cells tranformed with HTLV-1. Science 269, 79-83.
58. Yamamura, Y., Senda, H., Kageyama, Y., Matsuzaki, T., Noda, M., Ikawa, Y. (1998) Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells. Mol. Cell. Biol. 18, 1172-1180.
59. Briggs, S. D., Scholtz, B., Jacque, J-M., Swingler, S., Stevenson, M., Smithgall, T. E. (2001) HIV-1 Nef promotes survival of myeloid cells by a STAT3-dependent pathway. J. Biol. Chem. 276, 25605-25611.
60. Federico, M., Percario, Z., Olivetta, E., Fiorucci, G., Muratori, C., Micheli, A., Romeo, G., Affabris, E. (2001) HIV-1 Nef activates STAT1 in human monocytes/macrophages through the release of soluble factors. Blood 98, 2752-2761.
61. Oravecz, T., Norcross, M. A. (1993) Costimulatory properties of the human CD4 molecule: enhancement of CD3-induced T cell activation by human immunodeficiency virus type 1 through viral envelope glycoptrotein gp120. AIDS Res. Hum. Retroviruses 9, 945-955.
62. Berridge, M. (1997) Lymphocyte activation in health and disease. Crit. Rev. Immunol. 17, 155-178.
63. Fields, A. P., Bednarik, D. P., Hess, A., May, W. S. (1988) Human immunodeficiency virus induces phosphorylation of its cell surface receptor. Nature 333, 278-280.
64. Kowalski, M., Potz, J., Basiripour, L., Doffman, T., Goh, W. C., Terwilliger, E., Dayton, A., Rosen, C., Haseltine, W., Sodroski, J. (1987) Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237, 1351-1355.
65. Kornfeld, H., Cruikshank, W. W., Pyle, S. W., Berman, J. S., Center, D. M. (1988) Lymphocyte activation by HIV-1 envelope glycoprotein. Nature 335, 445-448.
66. Popik, W., Hesselgesser, J. E., Pitha, P. M. (1998) Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway. J. Virol. 72, 6406-6413.
67. Jabado, N., Pallier, A., Jauliac, S., Fischer, A., Hivroz, C. (1997) gp160 of HIV or anti-CD4 monoclonal antibody ligation of CD4 induces inhibition of JNK and ERK-2 activities in human peripheral CD4+ T lymphocytes. Eur. J. Immunol. 27, 397-404.
68. Sun, Y., Li, L., Lau, F., Beavo, J. A., Clark, E. A. (2000) Infection of CD4+ memory T cells by HIV-1 requires expression of phosphodiesterase. J. Immunol. 165, 1755-1761.
69. Navarro, J., Punzon, C., Jimenez, J. L., Fernandez-Cruz, E., Pizarro, A., Fresno, M., Munoz-Fernandez, M. A. (1998) Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: involvement of NF-κB and NFAT. J. Virol. 72, 4712-4720.
70. Angel, J. B., Saget, B. M., Walsh, S. P., Greten, T. F., Dinarello, C. A., Skolnik, P. R., Endres, S. (1995) Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication. AIDS 9, 1137-1144.
71. Selliah, N., Finkel, T. H. (1998) Cutting edge: JAK3 activation and rescue of T cells from HIV gp120-induced unresponsiveness. J. Immunol. 160, 5697-5701.
72. Romagnani, S., Abramson, I. (2000) T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 85, 9-18.
73. Altfeld, M., Addo, M. M., Kreuzer, K. A., Rockstroh, J. K., Dumoulin, F. L., Schliefer, K., Leifeld, L., Sauerbruch, T., Spengler, U. (2000) T(H)1 to T(H)2 shift of cytokines in peripheral blood of HIV-infected patients is detectable by reverse transcriptase polymerase chain reaction but not by enzyme-linked immunosorbent assay under nonstimulated conditions. J. Acquir. Immune Defic. Syndr. 23, 287-294.